Our paper was recently published in @JAMANetworkOpen
Doublet IO might benefit patients with pd-l1 negative squamous cell lung cancer.
jamanetwork.com/journals/jam...
I am a thoracic oncologist interested in clinical trials and healthcare policy administration.